[Analysis of etiology and complications in children with stage 5 chronic kidney disease].

To investigate the etiology, complications, and prognostic factors of stage 5 chronic kidney disease (CKD5) in children. A case series study was conducted to retrospectively analyze the general situation, clinical manifestations, laboratory tests, genetic testing, and follow-up data (until October 2022) of 174 children with CKD5 who were diagnosed and hospitalized at the Children's Hospital of Chongqing Medical University from April 2012 to April 2021. The characteristics of complications in the children were compared based on age, gender, and etiology. Based on the presence or absence of left ventricular hypertrophy (LVH), patients were divided into LVH group and non LVH group for analyzing the influencing factors of cardiovascular disease. Patients were also divided into death group and survival group, peritoneal dialysis group and hemodialysis group based on the follow-up data for analyzing the prognostic factors. The chi-square test, independent sample -test, Fisher exact probability test, Mann-Whitney test and Kruskal Wallis test were used to analyze data among different groups. Multivariate Logistic regression analysis was used to identify the prognostic factors. A total of 174 children with CKD5 were enrolled in the study (96 boys and 78 girls), aged 11.2 (8.2, 13.0) years. Congenital kidney and urinary tract malformations (CAKUT) were the most common causes of the CKD5 (84 cases, 48.3%), followed by glomerular diseases (83 cases, 47.7%), and among which 28 cases (16.1%) were hereditary glomerular diseases. The common complications of CKD5 included anemia (98.2%, 165/168), mineral and bone disorder in chronic kidney disease (CKD-MBD) (97.7%, 170/174), lipid metabolism disorders (87.5%, 63/72), hypertension (81.4%, 127/156) and LVH (57.6%,57/99). The incidences of hypertension in primary glomerular disease were higher than that in CAKUT(93.8%(30/32) 73.7%(56/76),=5.59,<0.05). The incidences of hypertension in secondary glomerular disease were higher than that in CAKUT and that in hereditary kidney disease (100.0%(20/20) 73.7%(56/76), 68.2%(15/22), both <0.05). The incidence of hypocalcemia in CAKUT, primary glomerular disease, and hereditary kidney disease was higher than that in secondary glomerular disease (82.1%(69/84), 88.2%(30/34), 89.3%(25/28) 47.6%(10/21), =10.21, 10.75, 10.80, all =0.001); the incidence of secondary hyperparathyroidism in women was higher than that in men (80.0%(64/80) 95.0%(57/60), =6.58, =0.010). The incidence of LVH in children aged 6-<12 was higher than that in children aged 12-18 (73.5%(25/34) 43.1%(22/51), =7.62, =0.006). Among 113 follow-up children, the mortality rate was 39.8% (45/113). Compared to the survival group, the children in the death group had lower hemoglobin, higher blood pressure, lower albumin, lower alkaline phosphatase and higher left ventricular mass index ((67±19) . (75±20) g/L, 142 (126, 154) . 128(113, 145) mmHg(1 mmHg=0.133 kPa), (91±21) . (82±22) mmHg, 32 (26, 41) . 40 (31, 43) g/L, 151 (82, 214) . 215 (129, 37) U/L, 48 (38, 66) . 38(32, 50) g/m,=2.03, =2.89, =2.70, =2.49, 2.79, 2.29,all <0.05), but no independent risk factors were identified (all >0.05). The peritoneal dialysis group had better alleviation for anemia, low calcium, and high phosphorus than the hemodialysis group ((87±22) (72±16) g/L, (1.9±0.5) (1.7±0.4) mmol/L, (2.2±0.7) (2.8±0.9) mmol/L, =2.92, 2.29, 2.82, all <0.05), and the survival rate of the peritoneal dialysis group was significantly higher than that of the hemodialysis group (77.8% (28/36) . 48.4% (30/62), =8.14, =0.004). CAKUT is the most common etiology in children with CKD 5, and anemia is the most common complication. The incidence of complications in children with CKD 5 varies with age, gender and etiology. Anemia, hypertension, hypoalbuminemia, reduced alkaline phosphatase and elevated LVMI may be the prognostic factors in children with CKD5. Peritoneal dialysis may be more beneficial for improving the long-term survival rate.